Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Shared Decision Making With Pharmaceutical Care (SDMPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02373059
Recruitment Status : Completed
First Posted : February 26, 2015
Last Update Posted : May 9, 2016
Sponsor:
Information provided by (Responsible Party):
Joseph R. Herges, Pharm.D., R.Ph., Mayo Clinic

Brief Summary:
A research study to enhance clinical discussion between patients and pharmacists using a shared decision making tool for type 2 diabetes or usual care.

Condition or disease Intervention/treatment Phase
Diabetes Other: Diabetes Issue Cards Decision Aids Other: Usual Pharmaceutical Care Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Examining the Use of a Shared Decision Making Tool With Pharmaceutical Care in Type 2 Diabetes
Study Start Date : February 2015
Actual Primary Completion Date : June 2015
Actual Study Completion Date : June 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Pharmaceutical care with shared decision making
Use of Diabetes Issue Cards Decision Aids
Other: Diabetes Issue Cards Decision Aids
Active Comparator: Usual Pharmaceutical care
Usual Care
Other: Usual Pharmaceutical Care



Primary Outcome Measures :
  1. Patient Involvement Questionnaire [ Time Frame: Post-Visit up to 2 weeks ]

Secondary Outcome Measures :
  1. Patient Knowledge regarding Diabetes treatments Questionnaire [ Time Frame: post visit up to 2 weeks ]
  2. Patient Medication Adherence Questionnaire [ Time Frame: 1 month post visit ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults ≥ 18 years of age
  • Diagnosed with type II diabetes by ICD-9 code for more than one year
  • HbA1c of 7%-9.5% within past 6 months
  • Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record

Exclusion Criteria:

  • Prescribed insulin
  • Pregnancy
  • Appointment with provider within a month
  • Appointment with provider within the last month
  • Followed by endocrinology

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02373059


Locations
Layout table for location information
United States, Minnesota
Mayo Clinic Kasson
Kasson, Minnesota, United States, 55944
Sponsors and Collaborators
Mayo Clinic
Layout table for additonal information
Responsible Party: Joseph R. Herges, Pharm.D., R.Ph., Doctor of Pharmacy, Mayo Clinic
ClinicalTrials.gov Identifier: NCT02373059    
Other Study ID Numbers: 14-009665
First Posted: February 26, 2015    Key Record Dates
Last Update Posted: May 9, 2016
Last Verified: May 2016